$INFU
InfuSystem Holdings, Inc Stock $infu

$infu Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000143774920018008 Filed on August 14, 2020

Income Statement

Concept	2020 Q2	2019 Q2	2019 Q1
Revenue	$26.00M	$19.72M	$18.19M
YoY Change	31.82%	20.15%	10.37%
Cost Of Revenue	$10.02M	$8.367M	$7.852M
YoY Change	19.77%	24.34%	25.71%
Gross Profit	$15.98M	$11.36M	$10.34M
YoY Change	40.7%	17.24%	1.02%
Gross Profit Margin	61.46%	57.58%	56.84%
Selling, General & Admin	$10.16M	$9.352M	$9.734M
YoY Change	8.63%	7.19%	15.03%
% of Gross Profit	63.58%	82.35%	94.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.932M	$1.224M	$1.225M
YoY Change	466.34%	-3.62%	-5.04%
% of Gross Profit	43.38%	10.78%	11.85%
Operating Expenses	$11.47M	$10.39M	$10.76M
YoY Change	10.47%	5.01%	11.52%
Operating Profit	$4.506M	$971.0K	-$420.0K
YoY Change	364.06%	-575.98%	-171.43%
Interest Expense	$332.0K	$488.0K	$460.0K
YoY Change	-31.97%	64.86%	46.03%
% of Operating Profit	7.37%	50.26%
Other Income/Expense, Net	-$9.000K	-$39.00K	-$21.00K
YoY Change	-76.92%	-4000.0%	90.91%
Pretax Income	$4.165M	$444.0K	-$901.0K
YoY Change	838.06%	-188.98%	-443.89%
Income Tax	$25.00K	$63.00K	$59.00K
% Of Pretax Income	0.6%	14.19%
Net Earnings	$4.140M	$381.0K	-$960.0K
YoY Change	986.61%	-175.45%	-570.59%
Net Earnings / Revenue	15.92%	1.93%	-5.28%
Basic Earnings Per Share	$0.21	$0.02	-$0.05
Diluted Earnings Per Share	$0.19	$0.02	-$0.05
COMMON SHARES
Basic Shares Outstanding	20.08M	19.71M	19.58M
Diluted Shares Outstanding	21.64M	20.58M	19.58M

Balance Sheet

Concept	2020 Q2	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$482.0K	$1.702M	$1.900M
YoY Change	-71.68%	-29.08%	26.67%
Cash & Equivalents	$482.0K	$1.702M	$1.900M
Short-Term Investments
Other Short-Term Assets	$1.457M	$1.368M	$1.470M
YoY Change	6.51%	-16.28%	31.96%
Inventory	$4.262M	$2.742M	$2.553M
Prepaid Expenses
Receivables	$16.61M	$11.22M	$10.48M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.81M	$17.03M	$16.40M
YoY Change	33.96%	7.26%	3.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.424M	$1.539M	$1.368M
YoY Change	187.46%	-0.06%	-11.51%
Goodwill
YoY Change
Intangibles	$13.31M	$17.62M	$18.74M
YoY Change	-24.43%	-20.51%	-19.66%
Long-Term Investments
YoY Change
Other Assets	$141.0K	$194.0K	$149.0K
YoY Change	-27.32%	41.61%	9.56%
Total Long-Term Assets	$61.16M	$55.33M	$50.85M
YoY Change	10.53%	16.15%	3.41%
TOTAL ASSETS
Total Short-Term Assets	$22.81M	$17.03M	$16.40M
Total Long-Term Assets	$61.16M	$55.33M	$50.85M
Total Assets	$83.97M	$72.36M	$67.25M
YoY Change	16.04%	13.92%	3.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.841M	$10.21M	$9.672M
YoY Change	-23.17%	70.53%	74.43%
Accrued Expenses		$1.374M	$1.479M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.526M	$6.084M	$5.337M
YoY Change	23.7%	100.33%	75.62%
Total Short-Term Liabilities	$20.12M	$20.53M	$18.48M
YoY Change	-2.03%	76.0%	69.37%
LONG-TERM LIABILITIES
Long-Term Debt	$33.34M	$27.48M	$27.52M
YoY Change	21.34%	25.12%	21.13%
Other Long-Term Liabilities	$4.192M	$4.021M	$1.479M
YoY Change	4.25%	2237.79%	7295.0%
Total Long-Term Liabilities	$33.34M	$52.11M	$47.50M
YoY Change	-36.01%	53.89%	40.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.12M	$20.53M	$18.48M
Total Long-Term Liabilities	$33.34M	$52.11M	$47.50M
Total Liabilities	$57.77M	$72.64M	$65.98M
YoY Change	-20.48%	59.55%	47.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$57.65M	-$63.31M	-$63.69M
YoY Change	-8.94%	2.22%	3.68%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.20M	$20.25M	$19.74M
YoY Change
Total Liabilities & Shareholders Equity	$83.97M	$72.36M	$67.25M
YoY Change	16.04%	13.92%	3.51%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	$4.140M	$381.0K	-$960.0K
YoY Change	986.61%	-175.45%	-570.59%
Depreciation, Depletion And Amortization	$6.932M	$1.224M	$1.225M
YoY Change	466.34%	-3.62%	-5.04%
Cash From Operating Activities	$3.705M	$3.050M	$1.269M
YoY Change	21.48%	-19.74%	20.51%
INVESTING ACTIVITIES
Capital Expenditures	-$4.927M	-$4.358M	-$3.535M
YoY Change	13.06%	169.01%	215.63%
Acquisitions
YoY Change
Other Investing Activities	$471.0K	$569.0K	$764.0K
YoY Change	-17.22%	-25.13%	-20.42%
Cash From Investing Activities	-$4.456M	-$3.789M	-$2.771M
YoY Change	17.6%	345.76%	1579.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	928.0K	541.0K	-916.0K
YoY Change	71.53%	-125.76%	-67.6%
NET CHANGE
Cash From Operating Activities	3.705M	3.050M	1.269M
Cash From Investing Activities	-4.456M	-3.789M	-2.771M
Cash From Financing Activities	928.0K	541.0K	-916.0K
Net Change In Cash	177.0K	-198.0K	-2.418M
YoY Change	-189.39%	-123.29%	24.7%
FREE CASH FLOW
Cash From Operating Activities	$3.705M	$3.050M	$1.269M
Capital Expenditures	-$4.927M	-$4.358M	-$3.535M
Free Cash Flow	$8.632M	$7.408M	$4.804M
YoY Change	16.52%	36.68%	121.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q2	infu	Finitelived Intangible Asset Expected Amortization Year Five And After FinitelivedIntangibleAssetExpectedAmortizationYearFiveAndAfter	2101000
CY2020Q2	infu	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3166000
CY2020Q2	infu	Longterm Debt Maturities Repayments Of Principal Year Four And Thereafter LongtermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter	15115000
CY2020Q2	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	2300000
	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	4400000
CY2019Q2	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	1800000
	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	3500000
CY2020Q2	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1297000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1306000
CY2020Q2	infu	Medical Equipment Held For Sale Or Rental Gross MedicalEquipmentHeldForSaleOrRentalGross	1311000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental Gross MedicalEquipmentHeldForSaleOrRentalGross	1334000
CY2020Q2	infu	Medical Equipment Held For Sale Or Rental Reserve MedicalEquipmentHeldForSaleOrRentalReserve	14000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental Reserve MedicalEquipmentHeldForSaleOrRentalReserve	28000
CY2020Q2	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	36962000
CY2019Q4	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	33225000
CY2020Q2	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	44094000
CY2019Q4	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	41908000
CY2020Q2	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	81842000
CY2019Q4	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	75853000
CY2020Q2	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	786000
CY2019Q4	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	720000
CY2020Q2	infu	Medical Equipment Net MedicalEquipmentNet	38259000
CY2019Q4	infu	Medical Equipment Net MedicalEquipmentNet	34531000
	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	8783000
	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	7595000
CY2020Q2	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	4776000
CY2019Q2	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	4100000
CY2020Q2	infu	Revenues External RevenuesExternal	25999000
CY2019Q2	infu	Revenues External RevenuesExternal	19723000
	infu	Revenues External RevenuesExternal	47552000
	infu	Revenues External RevenuesExternal	37916000
CY2020Q2	infu	Revenues Internal RevenuesInternal
CY2019Q2	infu	Revenues Internal RevenuesInternal
	infu	Revenues Internal RevenuesInternal
	infu	Revenues Internal RevenuesInternal
CY2020Q2	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	17000
CY2019Q4	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	17000
CY2020Q2	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	58000
CY2019Q4	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	66000
CY2020Q2	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Four And Thereafter UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFourAndThereafter	15000
CY2020Q2	infu	Unamortized Value Of Debt Issuance Costs Principal In Year One UnamortizedValueOfDebtIssuanceCostsPrincipalInYearOne	17000
CY2020Q2	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Three UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree	17000
CY2020Q2	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Two UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo	17000
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7841000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7962000
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16613000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12097000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2926000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2648000
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83845000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83699000
CY2019Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	171000
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	315000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	208000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	741000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	53000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	74000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	284000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	357000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	530000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	563000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	9000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	19000
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1075000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2150000
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1124000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2249000
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
CY2020Q2	us-gaap	Assets Assets	83969000
CY2019Q2	us-gaap	Assets Assets	72361000
CY2019Q4	us-gaap	Assets Assets	79224000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	22814000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	19305000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	482000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2647000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2647000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4318000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	482000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1702000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2165000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2616000
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23651557
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23400625
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20133068
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19882136
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	2000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10021000
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8367000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18911000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16219000
CY2020Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	9000
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	75000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	76000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	116000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	104000
	us-gaap	Depreciation Depreciation	4782000
	us-gaap	Depreciation Depreciation	3676000
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3530000
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3020000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6932000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5925000
CY2020Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	200000
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	400000
	us-gaap	Gross Profit GrossProfit	28641000
	us-gaap	Gross Profit GrossProfit	21697000
CY2020Q2	us-gaap	Gross Profit GrossProfit	15978000
CY2019Q2	us-gaap	Gross Profit GrossProfit	11356000
CY2019Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	100000
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	200000
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36474000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34324000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3930000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2135000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	548000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	548000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2051000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11313000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3224000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	837000
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7710000
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6876000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16362000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14009000
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	77000
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	303000
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4165000
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	444000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3776000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-457000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	122000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-956000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	364000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2115000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	643000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1363000
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	40868000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7804000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1055000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	488000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-205000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	123000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	165000
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1553115
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	875012
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1597627
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	49787000
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	49787000
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13313000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15463000
CY2020Q2	us-gaap	Interest Expense InterestExpense	332000
CY2019Q2	us-gaap	Interest Expense InterestExpense	488000
	us-gaap	Interest Expense InterestExpense	735000
	us-gaap	Interest Expense InterestExpense	948000
CY2020Q2	us-gaap	Inventory Net InventoryNet	4262000
CY2019Q4	us-gaap	Inventory Net InventoryNet	2899000
CY2020Q2	us-gaap	Lease Cost LeaseCost	481000
CY2019Q2	us-gaap	Lease Cost LeaseCost	343000
	us-gaap	Lease Cost LeaseCost	1017000
	us-gaap	Lease Cost LeaseCost	803000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	948000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	924000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	991000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	720000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2433000
CY2020Q2	us-gaap	Liabilities Liabilities	57767000
CY2019Q4	us-gaap	Liabilities Liabilities	56890000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83969000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79224000
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20117000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21847000
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1662000
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	141000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155000
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4750000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	38377000
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7526000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8082000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7778000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7053000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7275000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3647000
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33342000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30295000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2065000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-375000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8492000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6560000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4262000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4319000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	381000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	4140000
	us-gaap	Net Income Loss NetIncomeLoss	-579000
	us-gaap	Net Income Loss NetIncomeLoss	3722000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	11472000
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	10385000
	us-gaap	Operating Expenses OperatingExpenses	24102000
	us-gaap	Operating Expenses OperatingExpenses	21146000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4506000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	971000
	us-gaap	Operating Income Loss OperatingIncomeLoss	4539000
	us-gaap	Operating Income Loss OperatingIncomeLoss	551000
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	404000
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	290000
	us-gaap	Operating Lease Cost OperatingLeaseCost	828000
	us-gaap	Operating Lease Cost OperatingLeaseCost	677000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5371000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4192000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4644000
	us-gaap	Operating Lease Payments OperatingLeasePayments	789000
	us-gaap	Operating Lease Payments OperatingLeasePayments	771000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5018000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5733000
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y73D
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y109D
CY2020Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1457000
	us-gaap	Revenues Revenues	47552000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5803000
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-60000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	741000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	208000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	680000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	298000
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	250000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	26259000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2024000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	971000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1333000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	74000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	68000
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7350000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6685000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4424000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4037000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	523000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-190000
CY2020Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	238000
CY2019Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-91000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	23777000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	2256000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57645000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61367000
CY2020Q2	us-gaap	Revenues Revenues	25999000
CY2019Q2	us-gaap	Revenues Revenues	19723000
	us-gaap	Revenues Revenues	37916000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	118000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3015000
CY2020Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	75000
CY2019Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	83000
CY2020Q2	us-gaap	Variable Lease Cost VariableLeaseCost	77000
	us-gaap	Share Based Compensation ShareBasedCompensation	530000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	15000
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	15000
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	19743000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	20252000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	22020000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	26202000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	20441000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	22334000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19644590
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2449000
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2476000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5067000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5078000
	us-gaap	Share Based Compensation ShareBasedCompensation	563000
CY2019Q2	us-gaap	Variable Lease Cost VariableLeaseCost	53000
	us-gaap	Variable Lease Cost VariableLeaseCost	189000
	us-gaap	Variable Lease Cost VariableLeaseCost	126000
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21635705
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20583434
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21598071
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19644590
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20082590
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19708422
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20000444

Files In Submission

Name	View Source	Status
0001437749-20-018008-index-headers.html	Edgar Link	pending
0001437749-20-018008-index.html	Edgar Link	pending
0001437749-20-018008.txt	Edgar Link	pending
0001437749-20-018008-xbrl.zip	Edgar Link	pending
ex_198260.htm	Edgar Link	pending
ex_198261.htm	Edgar Link	pending
ex_198262.htm	Edgar Link	pending
ex_198263.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
infu-20200630.xml	Edgar Link	completed
infu-20200630.xsd	Edgar Link	pending
infu-20200630_cal.xml	Edgar Link	unprocessable
infu-20200630_def.xml	Edgar Link	unprocessable
infu-20200630_lab.xml	Edgar Link	unprocessable
infu-20200630_pre.xml	Edgar Link	unprocessable
infu20200630_10q.htm	Edgar Link	pending
logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INFU
InfuSystem Holdings, Inc Stock $infu

2020 Q2 Form 10-Q Financial Statement

#000143774920018008 Filed on August 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU InfuSystem Holdings, Inc Stock $infu

2020 Q2 Form 10-Q Financial Statement

#000143774920018008 Filed on August 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU
InfuSystem Holdings, Inc Stock $infu